-
Something wrong with this record ?
Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents
T. Zorbaz, D. Malinak, T. Hofmanova, N. Maraković, S. Žunec, NM. Hrvat, R. Andrys, M. Psotka, A. Zandona, J. Svobodova, L. Prchal, S. Fingler, M. Katalinić, Z. Kovarik, K. Musilek
Language English Country France
Document type Journal Article
- MeSH
- Acetylcholinesterase metabolism MeSH
- Butyrylcholinesterase metabolism MeSH
- Cholinesterase Inhibitors chemistry MeSH
- Halogens MeSH
- Mice MeSH
- Nerve Agents * pharmacology MeSH
- Organophosphorus Compounds MeSH
- Oximes chemistry MeSH
- Cholinesterase Reactivators * chemistry MeSH
- Sarin chemistry MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
The fluorinated bis-pyridinium oximes were designed and synthesized with the aim of increasing their nucleophilicity and potential to reactivate phosphorylated human recombinant acetylcholinesterase (AChE) and human purified plasmatic butyrylcholinesterase (BChE) in relation to chlorinated and non-halogenated oxime analogues. Compared to non-halogenated oximes, halogenated oximes showed lower pKa of the oxime group (fluorinated < chlorinated < non-halogenated) along with higher level of oximate anion formation at the physiological pH, and had a higher binding affinity of both AChE and BChE. The stability tests showed that the fluorinated oximes were stable in water, while in buffered environment di-fluorinated oximes were prone to rapid degradation, which was reflected in their lower reactivation ability. Mono-fluorinated oximes showed comparable reactivation to non-halogenated (except asoxime) and mono-chlorinated oximes in case of AChE inhibited by sarin, cyclosarin, VX, and tabun, but were less efficient than di-chlorinated ones. The same trend was observed in the reactivation of inhibited BChE. The advantage of halogen substituents in the stabilization of oxime in a position optimal for in-line nucleophilic attack were confirmed by extensive molecular modelling of pre-reactivation complexes between the analogue oximes and phosphorylated AChE and BChE. Halogen substitution was shown to provide oximes with additional beneficial properties, e.g., fluorinated oximes gained antioxidative capacity, and moreover, halogens themselves did not increase cytotoxicity of oximes. Finally, the in vivo administration of highly efficient reactivator and the most promising analogue, 3,5-di-chloro-bispyridinium oxime with trimethylene linker, provided significant protection of mice exposed to sarin and cyclosarin.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017791
- 003
- CZ-PrNML
- 005
- 20221025132931.0
- 007
- ta
- 008
- 220720s2022 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejmech.2022.114377 $2 doi
- 035 __
- $a (PubMed)35526478
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Zorbaz, Tamara $u Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, HR-10000, Zagreb, Croatia
- 245 10
- $a Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents / $c T. Zorbaz, D. Malinak, T. Hofmanova, N. Maraković, S. Žunec, NM. Hrvat, R. Andrys, M. Psotka, A. Zandona, J. Svobodova, L. Prchal, S. Fingler, M. Katalinić, Z. Kovarik, K. Musilek
- 520 9_
- $a The fluorinated bis-pyridinium oximes were designed and synthesized with the aim of increasing their nucleophilicity and potential to reactivate phosphorylated human recombinant acetylcholinesterase (AChE) and human purified plasmatic butyrylcholinesterase (BChE) in relation to chlorinated and non-halogenated oxime analogues. Compared to non-halogenated oximes, halogenated oximes showed lower pKa of the oxime group (fluorinated < chlorinated < non-halogenated) along with higher level of oximate anion formation at the physiological pH, and had a higher binding affinity of both AChE and BChE. The stability tests showed that the fluorinated oximes were stable in water, while in buffered environment di-fluorinated oximes were prone to rapid degradation, which was reflected in their lower reactivation ability. Mono-fluorinated oximes showed comparable reactivation to non-halogenated (except asoxime) and mono-chlorinated oximes in case of AChE inhibited by sarin, cyclosarin, VX, and tabun, but were less efficient than di-chlorinated ones. The same trend was observed in the reactivation of inhibited BChE. The advantage of halogen substituents in the stabilization of oxime in a position optimal for in-line nucleophilic attack were confirmed by extensive molecular modelling of pre-reactivation complexes between the analogue oximes and phosphorylated AChE and BChE. Halogen substitution was shown to provide oximes with additional beneficial properties, e.g., fluorinated oximes gained antioxidative capacity, and moreover, halogens themselves did not increase cytotoxicity of oximes. Finally, the in vivo administration of highly efficient reactivator and the most promising analogue, 3,5-di-chloro-bispyridinium oxime with trimethylene linker, provided significant protection of mice exposed to sarin and cyclosarin.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a butyrylcholinesterasa $x metabolismus $7 D002091
- 650 _2
- $a cholinesterasové inhibitory $x chemie $7 D002800
- 650 12
- $a reaktivátory cholinesterasy $x chemie $7 D002801
- 650 _2
- $a halogeny $7 D006219
- 650 _2
- $a myši $7 D051379
- 650 12
- $a nervová bojová látka $x farmakologie $7 D000067397
- 650 _2
- $a organofosforové sloučeniny $7 D009943
- 650 _2
- $a oximy $x chemie $7 D010091
- 650 _2
- $a sarin $x chemie $7 D012524
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Malinak, David $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003, Hradec Kralove, Czech Republic; Biomedical Research Center, University Hospital in Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic
- 700 1_
- $a Hofmanová, Tereza $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003, Hradec Kralove, Czech Republic $7 xx0278053
- 700 1_
- $a Maraković, Nikola $u Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, HR-10000, Zagreb, Croatia
- 700 1_
- $a Žunec, Suzana $u Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, HR-10000, Zagreb, Croatia
- 700 1_
- $a Hrvat, Nikolina Maček $u Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, HR-10000, Zagreb, Croatia
- 700 1_
- $a Andrys, Rudolf $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003, Hradec Kralove, Czech Republic
- 700 1_
- $a Psotka, Miroslav $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003, Hradec Kralove, Czech Republic; Biomedical Research Center, University Hospital in Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic $7 xx0277934
- 700 1_
- $a Zandona, Antonio $u Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, HR-10000, Zagreb, Croatia
- 700 1_
- $a Svobodová, Jana $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003, Hradec Kralove, Czech Republic $7 xx0145252
- 700 1_
- $a Prchal, Lukas $u Biomedical Research Center, University Hospital in Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic
- 700 1_
- $a Fingler, Sanja $u Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, HR-10000, Zagreb, Croatia
- 700 1_
- $a Katalinić, Maja $u Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, HR-10000, Zagreb, Croatia
- 700 1_
- $a Kovarik, Zrinka $u Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, HR-10000, Zagreb, Croatia. Electronic address: zkovarik@imi.hr
- 700 1_
- $a Musilek, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003, Hradec Kralove, Czech Republic; Biomedical Research Center, University Hospital in Hradec Kralove, Sokolska 581, 50005, Hradec Kralove, Czech Republic. Electronic address: kamil.musilek@uhk.cz
- 773 0_
- $w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 238, č. - (2022), s. 114377
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35526478 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20221025132930 $b ABA008
- 999 __
- $a ok $b bmc $g 1821745 $s 1169034
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 238 $c - $d 114377 $e 20220427 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
- LZP __
- $a Pubmed-20220720